Current Research and Scholarly Interests
Dr. Judith (Jodi) Prochaska is Senior Associate Vice Provost of Clinical Research Governance at Stanford University, a tenured Professor of Medicine, Deputy Director of the Stanford Prevention Research Center (SPRC), a member of the Stanford Cancer Institute, and a licensed clinical psychologist with addiction medicine privileges at Stanford Health Care. Her research program is leveraging technology to study tobacco, alcohol, and other drug use in populations at high risk. Her research spans community-based epidemiologic studies, randomized controlled treatment trials, and policy analysis. With attention to health disparities, communities of interest include Alaska Native men and women, people with co-occurring mental illness, the unemployed, the uninsured, and the unhoused. She has conducted and collaborated on over 25 randomized controlled behavioral intervention treatment trials, including two NIH SBIR awards – targeting tobacco and other substances of abuse – with participants across the age spectrum. She has disseminated the Rx for Change curriculum suite (http://rxforchange.ucsf.edu) with >10,000 registrants and 200,000 file downloads. She also developed an innovative free online CME program on e-cigarettes for health care providers with >1200 registrants, granting >900 CME units. She is a fellow and past president of the Society for Research on Nicotine and Tobacco (SRNT). She has published >300 peer-reviewed articles and serves on the Editorial Board of JAMA Internal Medicine. She is the editor for the Merck Manuals professional and consumer content focused on tobacco. She has consulted as a scientific expert with numerous federal agencies, including the CDC TIPS from former smokers campaign; FDA's Center for Tobacco Products PhenX panel for identification of best measures in tobacco regulatory research; NCI’s Division of Cancer Control and Population Sciences, advising on tobacco control research priorities for the next 10 years; and the Congressionally-mandated Federal Advisory Interagency Committee on Tobacco and Health with a focus on tobacco addiction, mental illness, and other addictions. She was a contributing author to the 2020 Surgeon General’s Report on Smoking Cessation. She helped develop and chaired for several years Stanford Medicine’s Community Advisory Board (CAB). She co-directs SPRC’s NHLBI T32 post-doctoral training program in cardiovascular disease prevention, has been a primary mentor and advisor on multiple mentored NIH K awards (K01, K23, K99/R00), and is the faculty director for Stanford’s Master of Science Program in Community Health and Prevention Research (CHPR). With CHPR, she teaches a foundational course on the development and application of behavior change theory.
